WallStreetZenWallStreetZen

NASDAQ: ENTX
Entera Bio Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ENTX stock forecasts and price targets.

Forecast return on equity

Is ENTX forecast to generate an efficient return?

Company
-205.72%
Industry
30.36%
Market
331.61%
ENTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENTX forecast to generate an efficient return on assets?

Company
-180.04%
Industry
14.37%
ENTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENTX earnings per share forecast

What is ENTX's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.68

ENTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTX$1.77N/AN/A
MREO$0.51$3.63+610.78%Strong Buy
ATOS$0.63$8.00+1,167.83%Buy
DOMH$5.02N/AN/A
VRCA$8.30$17.00+104.82%Strong Buy
View Top Biotech Stocks

Entera Bio Stock Forecast FAQ

What is ENTX's earnings growth forecast for 2026-2026?

(NASDAQ: ENTX) Entera Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Entera Bio's earnings in 2026 is -$10,781,000.

In 2026, ENTX is forecast to generate -$31,338,839 in earnings, with the lowest earnings forecast at -$30,109,865 and the highest earnings forecast at -$32,260,570.

If you're new to stock investing, here's how to buy Entera Bio stock.

What is ENTX's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: ENTX) forecast ROE is -205.72%, which is considered weak.

What is ENTX's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: ENTX) Entera Bio's current Earnings Per Share (EPS) is -$0.25. In 2026, ENTX's EPS is forecast to hit -$0.68 (min: -$0.66, max: -$0.70).

What is ENTX's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: ENTX) forecast ROA is -180.04%, which is lower than the forecast US Biotechnology industry average of 14.37%.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.